Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH notice was added announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.SummaryDifference0.7%

- Check8 days agoChange DetectedThe site footer now identifies the software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe label for the 'Find contact information' link was standardized in the UI (capitalization change). The record history section now shows Revision: v3.7.0 instead of v3.6.6, reflecting a site update.SummaryDifference0.2%

- Check56 days agoChange DetectedA new revision v3.6.6 has been added to the study record history, replacing the previous v3.6.5. This reflects an update to the record metadata rather than substantive content changes.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry Revision: v3.6.5 appears in the history. This replaces the previous Revision: v3.6.4 and signals a page version update.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.